Join to View Full Profile
12902 Usf Magnolia DrTampa, FL 33612
Phone+1 813-745-4673
Dr. Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 1985 - 1988
University of FloridaResidency, Internal Medicine, 1982 - 1985
University of LouisvilleMS, Biochemistry, 1982
University of Louisville School of MedicineClass of 1981
University of LouisvilleBA, Biology, Summa Cum Laude, 1974
Certifications & Licensure
FL State Medical License 1983 - 2022
KY State Medical License 1988 - 2002
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2017
Clinical Trials
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Start of enrollment: 1998 Jun 02
- Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide Start of enrollment: 2000 Jun 01
- CP-609,754 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2000 Jun 01
Publications & Presentations
PubMed
- 1 citationsEpigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.Rafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, Maria Silva, Xiaohong Zhao
Research Square. 2025-04-15 - 2 citationsThe Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.Praneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads, Maria Silva, Xiaohong Zhao
Cancer Research. 2025-01-15 - 14 citationsMelphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma.Joel G. Turner, Yan Cui, Alexis Bauer, Jana L. Dawson, Juan A Gomez
Cancer Research. 2020-10-06
Journal Articles
- An open label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin and dexamethasone in newly diagnosed myelomaNishihori T, Baz R, Shain K, Kim J, Ochoa-Bayona JL, Yue B, Sullivan D, Dalton W, Alsina M, Eur J Haematol, 1/20/2015
- Randomized trial of oral cyclophosphamide and veliparib in high-grade serous ovarian, primary peritoneal, or fallopian tube cancers, or BRAC-mutant ovarian cancerKummar S, Oza AM, Fleming GF, Sullivan DM, Gandara DR, Naughton MJ, Villalona-Calero MA, Morgan RJ, Szabo P, Youn A, Chen AP, Ji J, Allen DE, Lih C-J, Mehaffey MG, Wal..., Clin Cancer Res, 1/1/2015
- Selective nuclear export inhibitor KPT-330 enhances the antitumor activity of gemcitabine in human pancreatic cancerKazim S, Malafa MP, Coppola D, Husain K, Zibadi S, Kashyap T, Crochiere M, Landesman Y, Rashal T, Sullivan DM, Mahipal A, Mol Cancer Ther, 1/1/2015
Books/Book Chapters
Abstracts/Posters
- The Result of a Phase 1 Study of Selinexor in Combination with High-Dose Melphalan and Autologous Hematopoietic Cell Transplantation for Multiple MyelomaDaniel M Sullivan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Combined Dasatinib and Tricribine Treatment Synergistically Inhibits the Growth of Sarcoma Cells.Cubitt CL, Gump J, Fielding EN, Menth JL, Cheng J, Sebti SM, Sullivan DM, AACR Annual Meeting, 1/1/2008
- Topoisomerase II Alpha Trafficking Between the Nucleus and Cytoplasm Is Controlled by Phosphorylation of a Casein Kinase II Site in the Carboxy-Terminal Domain.Turner JG, Gump J, Fang B, Koomen J, Sullivan DM, AACR Annual Meeting, 1/1/2008
Lectures
- "XP01 and Nuclear Export Inhibitors in Multiple Myeloma and AML"1/24/2015
- "Overcoming drug-resistance in multiple myeloma by XPO1 inhibitor combination therapy".Barcelona, Spain - 1/18/2014
- The Impact of Precision Oncology on Clinical Trials: Solving the Puzzle.The Westin O'Hare, Chicago - 1/9/2014
Other
- Efficacy of Topoisomerase I and II Inhibitors in Combination with Standard Chemotherapeutic Agents (Ara-C and Daunorubicin) in the Management of Acute Myeloid Leukemia...Saba HI, Sullivan DM, Loughran Jr TP, Moscinski LC, Sullivan PA, Morelli GA
1/1/2003 - "Fractionation, kinetic properties, and inhibition by L-methionine analogs of rat liver and kidney methionine adenosyltransferase isozymes"Sullivan DM, M.S. Thesis, University of Louisville
1/1/1982
Press Mentions
Moffitt Research of Selinexor for Relapsed/Refractory Multiple Myeloma Facilitates Recent FDA ApprovalJuly 24th, 2019
ORIEN Uses Big Data to Improve Care for High-Risk PatientsJune 12th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










